期刊文献+

前列腺增生症合并的前列腺炎症对病人下尿路症状的影响 被引量:1

The Effect of Prostatic Inflammation Complicated by Benign Prostatic Hyperplasia on Low Urinary Tract Symptoms
下载PDF
导出
摘要 目的:探讨前列腺增生症合并的前列腺炎症对病人下尿路症状的影响因素。方法:纳入行经尿道前列腺电切术的前列腺增生症病人52例,术前作尿常规分析、经直肠前列腺B超、尿流动力检查、评估国际前列腺症状评分;术中取切取的前列腺组织作病理检查,诊断有无前列腺炎症、炎症程度和炎症类型。采用多元逐步线性回归方法分析前列腺腺体炎症、前列腺腺周炎症、尿路感染、前列腺体积、最大尿流率、逼尿肌是否受损、年龄对国际前列腺症状评分的影响。结果:前列腺炎症和前列腺增生症病人与国际前列腺症状评分无关。结论:本组前列腺增生症病人的下尿路症状和前列腺组织学炎症无关。 Objective: To study the effect of the inflammation in benign prostatic hyperplasia (BPH) patients on low urinary tract symptoms (IPSS). Methods: 52 in - patients with BPH were enrolled from September to December 2006 in West China Hospital of Siehuan University. Urine laboratory examination, urodynamie examination and transrectal ultrasonography were performed and IPSS was estimated before TURP. Deep random prostatic gland tissues were collected after resection of the prostatic urethra by the resectoscope sheath for the pathologic examination. The possible risk factors for IPSS were analyzed with the method of linear regression. Results : Prostatic inflammation was not associated with International Prostate Symptom Score. Conclusion: Prostatic inflammation was not the risk factors of LUTS in the BPH patients undergoing TURP in the present study.
出处 《包头医学院学报》 CAS 2008年第6期576-578,共3页 Journal of Baotou Medical College
关键词 前列腺增生症 炎症 国际前列腺症状评分 线性回归 Benign prostatic hyperplasia Inflammation International prostate symptom score Linear regression
  • 相关文献

参考文献10

二级参考文献25

  • 1赵永久,任福金,詹朝辉,朱肖峰.良性前列腺增生与下尿路症状及急性尿潴留的关系[J].现代泌尿外科杂志,2004,9(3):172-174. 被引量:7
  • 2夏同礼,孔祥田.我国成人前列腺发育的初步报告[J].中华泌尿外科杂志,1993,14(4):287-289. 被引量:25
  • 3夏同礼,邓方明,杨建茹,何其华,顾方六,郭应禄.国人正常前列腺组织成分定量分析[J].中华泌尿外科杂志,1995,16(6):345-347. 被引量:22
  • 4Blumenfeld W, Tucci S, Narayan P. Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands[J]. Am J Surg Pathol, 1992,16(10) :975-981.
  • 5Gerstenbluth RE, Steftel AD, MacLennan GT, et al. Distribution of chronic prostatitis in radical prostatectomy specimens with upregulation of Bcl-2 in areas of inflammation [ J]. J Urol, 2002,167(5 ) :2267-2270.
  • 6Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis[ J ]. JAMA, 1999, 282 (3) : 236-237.
  • 7Irani J, Levillain P, Goujon JM, et al. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value[J]. J Urol,1997,157(4) :1301-1303.
  • 8Colombel M, Vacherot S, Diez SE, et al. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia[J]. Br J Urol, 1998, 82(3) :380-385.
  • 9Steiner G, Gessl A, Kramer G, et al. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia[J]. J Urol, 1994, 151(2):480-484.
  • 10Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study. BJU Int, 2003, 92(4):409.

共引文献200

同被引文献12

  • 1王尉,胡卫列,杨槐,邱晓拂,张长征.抗生素及非甾体类消炎药对ⅢA型前列腺炎血清PSA及游离PSA的影响[J].中华男科学杂志,2006,12(9):787-790. 被引量:10
  • 2高为,汪玉宝.吲哚美辛栓联合曲唑酮治疗Ⅲ型前列腺炎的临床研究[J].中国男科学杂志,2007,21(11):36-39. 被引量:7
  • 3Wang X, Lin W J, Izumi K, et :. Increased infiltrated macrophages in benign prostatic hyperplasia(bph) :role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation [ J ]. J Biol Chem, 2012; 287 (22) : 18376-18385.
  • 4Bostanci Y, Kazzazi A, Momtahen S, et al. Correlation between benign prostatic hyperplasia and inflammation [J]. Curr Opin Urol,2013 ;23( 1 ) :5-10.
  • 5Araki T, Yokoyama T, Kumon H. Effectiveness of a nonsteroidal anti- inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping [ J ]. Acta Med Okayama, 2004 ; 58 ( 1 ) :45-49.
  • 6Di silverio F, Bosman C, Salvatori M, et al. Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms ( luts ) and benign prostatic hyperplasia( bph ) [ J ]. Eur Urol, 2005 ;47 ( 1 ) : 72 -78.
  • 7Falahatkar S, Mokhtari G, Pourreza F, et al. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, Randomized, Double - blind, Placebo- controlled study [ J ]. Urology, 2008 ; 72 ( 4 ) : 813-816.
  • 8Kahokehr A, Vather R, Nixon A, et al. Non-steroidal anti -inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia:systematic review and meta- analysis of randomized controlled trials [ J ]. BJU Int, 2013;111(2) :304-311.
  • 9Minnery CH, Getzenberg RH. Benign prostatic hyperplasiacell line viability and modulation of jm-27by doxazosin and ibuprofen[ J]. J Urol,2005 ;174( 1 ) :375-379.
  • 10St sauver JL, Lieber MM, Slager SL, et al. Associations between variants in the cyclooxygenase 2 enzyme gene (ptgs2) and development of benign prostate enlargement [J]. BJU Int,2011 ;108(10) :1610-1615.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部